Lymphomatoid Granulomatosis
Showing 26 - 50 of 201
Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome Trial (NS-229, Placebo)
Not yet recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- Churg-Strauss Syndrome
- NS-229
- Placebo
- (no location specified)
Sep 14, 2023
Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Myeloid Leukemia Trial in Detroit (Dasatinib, laboratory biomarker analysis)
Terminated
- Non-Hodgkin's Lymphoma
- +5 more
- Dasatinib
- laboratory biomarker analysis
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Dec 14, 2020
MoMa Signature During Granulomatosis
Not yet recruiting
- Sarcoidosis
- Tuberculosis
- blood sample
-
Paris, FranceHôpital Bichat
Jun 14, 2023
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit, Cleveland, Philadelphia (educational
Completed
- Brain and Central Nervous System Tumors
- +8 more
- educational intervention
-
Detroit, Michigan
- +3 more
Jul 23, 2020
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (donor lymphocytes)
Completed
- Leukemia
- +3 more
- donor lymphocytes
-
Buffalo, New YorkRoswell Park Cancer Institute
Aug 21, 2020
Kidney Cancer, Leukemia, Lymphoma Trial in United States (glutamic acid, )
Completed
- Kidney Cancer
- +5 more
- glutamic acid
- placebo
-
Fort Myers, Florida
- +5 more
Jul 22, 2021
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Minneapolis (drug, biological, radiation)
Completed
- Leukemia
- +2 more
- busulfan
- +3 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Nov 12, 2020
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Spartanburg, Houston (methadone HCl, morphine
Terminated
- Brain and Central Nervous System Tumors
- +10 more
- methadone hydrochloride
- +2 more
-
Spartanburg, South Carolina
- +1 more
Sep 1, 2020
Non-Hodgkins Lymphoma, Solid Tumor Trial in Vancouver, Ottawa (Aurora kinase inhibitor AT9283)
Completed
- Non-Hodgkins Lymphoma
- Unspecified Adult Solid Tumor, Protocol Specific
- Aurora kinase inhibitor AT9283
-
Vancouver, British Columbia, Canada
- +1 more
Apr 6, 2020
Granulomatosis With Polyangiitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Paris (Rituximab,
Not yet recruiting
- Granulomatosis With Polyangiitis
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
- Rituximab
- +2 more
-
Paris, FranceHôpital de la Croix Saint Simon
Oct 10, 2022
Wegener's Granulomatosis or Microscopic Polyangiitis Trial in India (Methylprednisolone, Prednisone, Rituximab)
Completed
- Wegener's Granulomatosis or Microscopic Polyangiitis
- Methylprednisolone
- +2 more
-
Hyderabad, Andhra Pradesh, India
- +9 more
Jul 4, 2022
Non-Hodgkin's Lymphoma, Multiple, Mycosis Fungoides Trial in Detroit (Dasatinib)
Terminated
- Non-Hodgkin's Lymphoma
- +4 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 12, 2020
Eosinophilic Granulomatosis With Polyangiitis Trial in Paris (Rituximab, Azathioprine, Placebo-rituximab)
Recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- Rituximab
- +3 more
-
Paris, FranceHôpital Cochin
Feb 9, 2022
B-cell Adult Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma Trial in
Terminated
- B-cell Adult Acute Lymphoblastic Leukemia
- +26 more
- 6,8-bis(benzylthio)octanoic acid
- +3 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jun 29, 2018
Granulomatosis With Polyangiitis and Microscopic Polyangiitis
Completed
- Granulomatosis With Polyangiitis
- +2 more
-
Boston, Massachusetts
- +7 more
Jul 11, 2022
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
Recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- Churg-Strauss Syndrome
-
San Diego, California
- +9 more
May 16, 2022
ANCA Associated Vasculitis, Microscopic Polyangiitis, Churg-Strauss Syndrome Trial in United Kingdom (Hydroxychloroquine,
Recruiting
- ANCA Associated Vasculitis
- +3 more
- Hydroxychloroquine
- Placebo
-
Cardiff, United Kingdom
- +8 more
Mar 17, 2022
Effectiveness of Eosinophilic Granulomatosis With Polyangiitis
Active, not recruiting
- Churg-Strauss Syndrome
-
Aichi, Japan
- +33 more
Sep 20, 2022
Lymphoma, Solid Tumor Trial in Hamilton, Toronto (CDKI AT7519, laboratory biomarker analysis)
Completed
- Lymphoma
- Unspecified Adult Solid Tumor, Protocol Specific
- CDKI AT7519
- laboratory biomarker analysis
-
Hamilton, Ontario, Canada
- +1 more
Apr 6, 2020
Eosinophilic Granulomatosis With Polyangiitis Trial (SHR-1703, SHR-1703 Placebo)
Not yet recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- SHR-1703
- SHR-1703 Placebo
- (no location specified)
Jul 30, 2023
Granulomatosis With Polyangiitis (Wegener's), Granulomatosis With Polyangiitis, Wegener's Granulomatosis Trial in Worldwide
Recruiting
- Granulomatosis With Polyangiitis (Wegener's)
- +3 more
- Abatacept
- placebo
-
Los Angeles, California
- +19 more
May 2, 2022
Granulomatosis With Polyangiitis Trial in Shanghai (Tofacitinib, Methotrexate)
Recruiting
- Granulomatosis With Polyangiitis
-
Shanghai, Shanghai, ChinaDepartment of Rheumatology in Zhongshan hospital, Fudan Universi
Jul 5, 2021
Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA) Trial in Worldwide (IFX-1, Placebo-IFX-1, Glucocorticoid
Completed
- Granulomatosis With Polyangiitis (GPA)
- Microscopic Polyangiitis (MPA)
- IFX-1
- +3 more
-
Leuven, Belgium
- +75 more
Aug 3, 2022
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Terminated
- Accelerated Phase Chronic Myelogenous Leukemia
- +110 more
- rituximab
- +12 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Feb 6, 2019
Biosimilars of Rituximab in ANCA-associated Vasculitis Compared
Recruiting
- ANCA-associated Vasculitis
- +2 more
-
Calgary, Alberta, Canada
- +8 more
Jan 27, 2023